[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2

• Authors:
  • Loredana Moro
  • Arnaldo A. Arbini
  • Ersilia Marra
  • Margherita Greco

• View Affiliations

  
  Affiliations: Institute of Biomembranes and Bioenergetics, National Research Council (C.N.R.), Bari 70126, Italy, Department of Pathology and Laboratory Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, NY 14642, USA
• Published online on: April 14, 2016     https://doi.org/10.3892/ijo.2016.3487
• Pages: 2722-2722

• Copyright: © Moro et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Article

Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2

LOREDANA MORO, ARNALDO A. ARBINI, ERSILIA MARRA and MARGHERITA GRECO

[Related article:] Int J Oncol 30: 217–224, 2007; DOI: 10.3892/ijo.30.1.217

After the publication of the article the authors noted the following errors in the assembling of the figures. In Fig. 3A the tubulin panel for PC-3 cells is incorrect. The correct panel is reported below. In Figs. 3B and 5B the panels are incorrect. The correct panels are shown below. These changes do not affect the interpretation of the data or conclusions of this work.

Figure 3

Figure 5

Figure 3

Figure 5